Tsokos M, Reichelt U, Jung R, Nierhaus A, Püschel K
Institute of Legal Medicine, University of Hamburg, Butenfeld 34, D-22529, Hamburg, Germany.
Forensic Sci Int. 2001 Jun 1;119(1):47-56. doi: 10.1016/s0379-0738(00)00391-1.
Postmortem interleukin-6 (IL-6) and C-reactive protein (CRP) serum levels were investigated prospectively in sepsis-related fatalities and non-septic fatalities by using a linear regression model. At least three blood samples were collected between 0.3 and 139 h postmortem from sepsis-related fatalities (n=8) and non-septic fatalities (n=16). In addition, one antemortem blood sample was collected shortly before death from the septic patients. Antemortem and postmortem IL-6 and CRP levels were highly elevated in all individuals included in the sepsis group. An excessive postmortem increase of IL-6 serum levels associated with progressive time after death was observed in five out of the eight septic patients. Both, IL-6 and CRP serum concentrations seem to be suitable biochemical postmortem markers of sepsis. The determination of IL-6 serum levels above 1500 pg/ml in peripheral venous blood obtained in the early postmortem interval can be considered as a diagnostic hint towards an underlying septic condition. A more precise postmortem discrimination between sepsis and non-septic underlying causes of death is provided by the postmortem measurement of serum CRP in peripheral venous blood: on condition that at least two postmortem CRP values have been determined at different time points postmortem, the CRP level of a deceased at the time of death can be calculated by using linear regression analysis. When assessing postmortem IL-6 and CRP concentrations as biochemical postmortem markers of sepsis, various clinical conditions, such as a preceding trauma or burn injury going along with elevated IL-6 and/or CRP levels prior to death as a result of the systemic inflammatory response syndrome (SIRS) should be taken into consideration, thus adding relevant information for the practical interpretation of the results.
通过线性回归模型,对脓毒症相关死亡病例和非脓毒症死亡病例的死后白细胞介素-6(IL-6)和C反应蛋白(CRP)血清水平进行了前瞻性研究。在死后0.3至139小时内,从脓毒症相关死亡病例(n = 8)和非脓毒症死亡病例(n = 16)中至少采集三份血样。此外,在脓毒症患者死亡前不久采集一份生前血样。脓毒症组所有个体的生前和死后IL-6及CRP水平均显著升高。在8例脓毒症患者中的5例中,观察到死后IL-6血清水平随死亡时间的延长而过度升高。IL-6和CRP血清浓度似乎都是脓毒症合适的死后生化标志物。在死后早期外周静脉血中测得IL-6血清水平高于1500 pg/ml,可被视为存在潜在脓毒症的诊断线索。通过对外周静脉血中血清CRP进行死后测量,可以更精确地区分脓毒症和非脓毒症的潜在死因:前提是在死后不同时间点至少测定了两份死后CRP值,可通过线性回归分析计算死者死亡时的CRP水平。在将死后IL-6和CRP浓度评估为脓毒症的生化死后标志物时,应考虑各种临床情况,例如先前的创伤或烧伤,由于全身炎症反应综合征(SIRS)在死亡前会伴有IL-6和/或CRP水平升高,从而为结果的实际解读提供相关信息。